Reply to "Comment on 'On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens'"
- PMID: 28055946
- PMCID: PMC5224935
- DOI: 10.1289/EHP1122
Reply to "Comment on 'On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens'"
Conflict of interest statement
B.B. is a named inventor on U.S. patents 5,861,274; 6,200,802; 6,815,168; and 7,250,273, all of which are related to PPARγ. The other authors declare they have no actual or potential competing financial interests.
Comment on
-
On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens.Environ Health Perspect. 2016 Aug;124(8):1214-26. doi: 10.1289/ehp.1510352. Epub 2016 Jan 13. Environ Health Perspect. 2016. PMID: 26757984 Free PMC article.
-
Comment on "On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens".Environ Health Perspect. 2017 Jan 1;125(1):A8-A11. doi: 10.1289/EHP881. Environ Health Perspect. 2017. PMID: 28055944 Free PMC article. No abstract available.
References
-
- Auerbach S, Filer D, Reif D, Walker V, Holloway AC, Schlezinger J, et al. 2016. Prioritizing environmental chemicals for obesity and diabetes outcomes research: a screening approach using Toxcast™ high-throughput data. Environ Health Perspect 124 8 1141 1154, doi: 10.1289/ehp.1510456 - DOI - PMC - PubMed
-
- Judson RS, Magpantay FM, Chickarmane V, Haskell C, Tania N, Taylor J, et al. 2015. Integrated model of chemical perturbations of a biological pathway using 18 in vitro high-throughput screening assays for the estrogen receptor. Toxicol Sci 148 1 137 154, doi: 10.1093/toxsci/kfv168 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources